Palivizumab for respiratory syncytial virus prophylaxis

This publication has 12 references indexed in Scilit:

• Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV
  Pediatrics, 1998
• RESPIRATORY SYNCYTIAL VIRUS VACCINES
  The Pediatric Infectious Disease Journal, 1998
• Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia
  The Pediatric Infectious Disease Journal, 1998
• Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants
  Pediatrics, 1998
• Respiratory syncytial virus-immunoglobulin intravenous (RSV-IGIV) for respiratory syncytial viral infections: Part II
  Journal of Pediatric Health Care, 1998
• Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus
  The Journal of Infectious Diseases, 1997
• Respiratory syncytial virus-immunoglobulin intravenous (RSV-IGIV) for respiratory syncytial viral infections: Part I
  Journal of Pediatric Health Care, 1997
• Respiratory Syncytial Virus Immune Globulin Intravenous: Indications for Use
  Pediatrics, 1997
• Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin Prophylaxis
  Pediatrics, 1997
• Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children
  New England Journal of Medicine, 1993